STAT

China may compete with the West for limited opportunities to test Ebola vaccine

China is making a bid to use its Ebola vaccine in the DRC, which could further complicate efforts to test a crowded field of vaccines and therapies in the context…
Health workers operate within an Ebola safety zone in the health center in Iyonda, near Mbandaka, Democratic Republic of the Congo, on June 1.

China is making a bid to use its Ebola vaccine in the Democratic Republic of the Congo. It’s a move that could further complicate efforts to test a crowded field of vaccines and therapies in the context of a waning outbreak.

The head of the Chinese Center for Disease Control and Prevention (CDC), Gao Fu, is reported to have said that a team of experts will travel to the DRC on Friday, bringing with them an unspecified number of doses of vaccine.

“We will seek to use the Chinese developed vaccine there to help with control and prevention of the disease, but for the present the vaccines will likely only cover Chinese living in Congo,” Gao is reported as saying in .

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Pfizer’s DTC Platform, Sandoz’s Feud With A U.K. Trade Group, And More
Pfizer filed a trademark application last month for a website and app providing medical information and mail-order pharmacy and telehealth services to U.S. patients.
STAT1 min read
STAT+: Microsoft’s Peter Lee Says ChatGPT Shouldn’t Be Used For Initial Diagnosis
Speaking at #STATBreakthrough Summit, Microsoft’s Peter Lee talked about how ChatGPT and generative AI still have tricky blindspots.
STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

Related Books & Audiobooks